
VoyoCare Review
Tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.7/10
Best for: compounded tirzepatide with a named medical group and pharmacies, if the $299 start price suits you
VoyoCare scores highest on state availability and ease of access.
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
VoyoCare is a telehealth brand of PYLOT LLC in Wyoming that offers compounded tirzepatide through DrTelx, an independent medical group, with prescriptions filled by partner pharmacies including EPIQ Scripts. Its tirzepatide page lists a starting price of $299 a month with the consultation, ongoing support and free shipping included, though the homepage says pricing is shared after your consultation. Your card is held and only charged once a doctor approves you.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to VoyoCare
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
VoyoCare at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Tirzepatide
- Starting price
- $299/mo (starting dose)
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored VoyoCare
Each dimension is scored algorithmically from VoyoCare’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
5.1/10At $299/mo (starting dose), VoyoCare runs about 64% above the $182 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
7.5/10VoyoCare offers tirzepatide, which produced the largest average weight loss of any GLP-1 in head-to-head trials.
User Experience15%
6.7/10Online intake and platform experience (consult included in the price); 5 platform features disclosed.
Trust & Safety15%
7.8/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.0/10VoyoCare treats patients in all 50 states plus DC.
Support10%
5.5/10VoyoCare provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this VoyoCare review
Last checked November 2026- Confirmed current pricing across 1 dose/plan tier
- Confirmed availability in all 50 states plus DC
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $299/mo across 1 dose/plan tier (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with VoyoCare
We walked VoyoCare’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1'Start your consultation' opens VoyoCare's online intake on a separate site
- 2The first screen asks your primary health goal, then continues into a medical questionnaire
- 3VoyoCare says a DrTelx provider reviews your answers by chat or video depending on your state
- 4A hold is placed on your card at checkout, and payment is processed only after a doctor approves you
- The tirzepatide page shows 'starts at $299.00/mo', but the homepage plan card says pricing is shared after your consultation
- Prices for higher doses or longer plans are not published on the site
- The refund policy and parts of the tirzepatide page refer to another company, Remote Pharmacy
- The homepage promises a six-month money-back guarantee, but the terms it links to don't describe one
VoyoCare customer support
- info@voyocare.com
GLP-1 medications VoyoCare offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Listed as 'starts at $299.00/mo' with the prescription, doctor consultation, ongoing support and free shipping included; prices at higher doses are not published.
Ready to get started?
Plans and promotions change often, so check VoyoCare's current pricing and active discounts before you decide.
What we like
- Names its medical group, DrTelx, and partner pharmacies including EPIQ Scripts, Foothills and Emerald
- LegitScript seal served from LegitScript's own site
- Says care is available in all 50 states and DC, fully online in most of them
- The tirzepatide price includes the doctor consultation, ongoing support and free shipping
- Your card is held, not charged, until a doctor approves you
- Cancel online from your account or by email, with no phone call needed
Watch-outs
- The homepage says pricing comes after your consultation, and only a 'starts at $299' tirzepatide price is published
- Tirzepatide at $299 a month is above the roughly $249 median we track
- Its refund page and tirzepatide page use another company's name, Remote Pharmacy, and its terms are labeled a general template
- The six-month money-back guarantee points to its terms, which don't describe it
- A $30 doctor fee is kept if you cancel after the consultation but before your order ships
- Shipped medication can't be refunded
- Support is email and a contact form only, with no phone number
- A live video or phone visit is required in six states and DC
Is VoyoCare worth it?
The short version of what VoyoCare offers is compounded tirzepatide with a named medical group and pharmacies, if the $299 start price suits you. It runs $299/month (starting dose); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. It treats patients in every state, so where you live isn't a reason to rule it out.
On top of the core program, it is LegitScript-certified and names the pharmacy that fills its prescriptions.
How much VoyoCare costs
Compounded tirzepatide runs $299/month (starting dose), which is the figure its own site lists for it.
Because VoyoCare's headline figure is a starting dose, we don't set it against the roughly $182 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare VoyoCare with the month-to-month prices of the alternatives below instead.
MEDGm (about $299/month) is one of the closest alternatives to weigh VoyoCare against.
Medications: what VoyoCare prescribes
VoyoCare prescribes tirzepatide (the active drug in Zepbound and Mounjaro), one of the most clinically proven GLP-1 options. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who VoyoCare is best for, and who should skip it
A good fit if you…
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
VoyoCare treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
VoyoCare is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
VoyoCare scores highest on state availability and ease of access.
Ready to start with VoyoCare?
From $299/mo (starting dose). See current pricing and start your free consultation.
VoyoCare might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare VoyoCare vs…
VoyoCare scores6.7/10
Side-by-side pricing, medications and scores. Pick a matchup.
VoyoCare vs Amazon One Medical
Amazon One Medical scores 8.5/10

VoyoCare vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this VoyoCare review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 7.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See VoyoCare's current pricing
Plans from $299/mo (starting dose). Start your free consultation to check eligibility and today's price.